Evidence map›Paper›PMID 30419043›Full record

ArticlePloS one2018

Regulating transcriptional activity by phosphorylation: A new mechanism for the ARX homeodomain transcription factor.

Tessa Mattiske, May H Tan, Oliver Dearsley, Desiree Cloosterman, Charles S Hii, Jozef Gécz, Cheryl Shoubridge

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Cellular Functional Analyses ofHuman mutation · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. International journal of molecular sciences · 2019
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tessa MattiskeAdelaide Medical School, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-9581-5370
May H TanAdelaide Medical School, University of Adelaide, Adelaide, Australia.
Oliver DearsleyAdelaide Medical School, University of Adelaide, Adelaide, Australia.
Desiree CloostermanAdelaide Medical School, University of Adelaide, Adelaide, Australia.
Charles S HiiDepartment of Immunopathology, SA-Pathology, Adelaide, Australia.
Jozef GéczAdelaide Medical School, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-7884-6861
Cheryl ShoubridgeAdelaide Medical School, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-0157-3084
The University of Adelaide · AUSouth Australian Health and Medical Research Institute · AUSouth Australia Pathology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aristaless-related homeobox (ARX) gene encodes a paired-type homeodomain transcription factor with critical roles in development. Here we identify that ARX protein is phosphorylated. Using mass spectrometry and in vitro kinase assays we identify phosphorylation at serines 37, 67 and 174. Through yeast-2-hybrid and CoIP we identified PICK1 (Protein interacting with C kinase 1) binding with the C-terminal region of ARX. PICK1 is a scaffold protein known to facilitate phosphorylation of protein partners by protein kinase C alpha (PRKCA). We confirm that ARX is phosphorylated by PRKCA and demonstrate phosphorylation at serine 174. We demonstrate that phosphorylation is required for correct transcriptional activity of the ARX protein using transcriptome-wide analysis of gene expression of phospho-null mutants (alanines replacing serines) compared to ARX wild-type (ARX-WT) overexpressed in pancreatic alpha TC cells. Compared to untransfected cells, ARX-WT overexpression significantly altered expression of 70 genes (Log2FC >+/-1.0, P-value <0.05). There were fewer genes with significantly altered expression compared to untransfected cells with the double phospho-null mutant Ser37Ala+Ser67Ala (26%) and Ser174Ala (39%), respectively. We demonstrate that the c-terminal region of ARX required to bind PICK1 causes a shift in PICK1 subcellular localisation to the nucleus to co-locate with the ARX protein, and truncation of this C-terminal region leads to the same loss of transcriptional activation as S174A mutant. In conclusion, we show that ARX is phosphorylated at several sites and that this modification affects its transcriptional activity.

Indexed as

AnimalsCarrier ProteinsCell NucleusGene Expression ProfilingGene Expression Regulation, DevelopmentalGlucagon-Secreting CellsHEK293 CellsHomeodomain ProteinsHumansMiceMutationNuclear ProteinsPhosphorylationProtein Kinase C-alphaSerineTranscription FactorsARX protein, humanCarrier ProteinsHomeodomain ProteinsNuclear ProteinsPICk1 protein, humanPRKCA protein, humanProtein Kinase C-alphaSerineTranscription Factors

Identifiers

PMID30419043
PMCPMC6231642
OpenAlexW2900671713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.